$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
How long does it take for dimethyl fumarate (Tecfidera) to be effective?
2026-02-01 22:25:32
Check Details
The difference between dimethyl fumarate (Tecfidera) and sodium bisulfite
2026-02-01 22:25:32
Check Details
Dosage and usage of dimethyl fumarate (Tecfidera)
2026-02-01 22:25:32
Check Details
How much does the original drug of Bogen dimethyl fumarate (Tecfidera) cost?
2026-02-01 22:25:32
Check Details
Warnings and precautions for using dimethyl fumarate (Tecfidera)
2026-02-01 22:25:32
Check Details
Instructions for Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf)
2026-02-01 22:25:32
Check Details
What are the precautions for Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf)?
2026-02-01 22:25:32
Check Details
What is Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf)?
2026-02-01 22:25:32
Check Details
Efficacy of Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf)
2026-02-01 22:25:32
Check Details
Is Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) on the market?
2026-02-01 22:25:32
Check Details
How much does Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) cost?
2026-02-01 22:25:32
Check Details
What are the side effects of Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf)?
2026-02-01 22:25:32
Check Details
1
2
...
295
296
297
298
299
300
301
...
10221
10222
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Leflunomide and Ocular Adverse Effects: Risk Awareness and Clinical Guidance
2
Clinical Management of Acquired Resistance to Garsorasib (KRAS G12C Inhibitor)
3
Chemical Structure of Capivasertib: A Novel AKT Inhibitor
4
Avatrombopag (Doptelet): Oral TPO-RA for Multiple Thrombocytopenia Types
5
Capivasertib: An AKT Inhibitor for Breast and Prostate Cancer
6
Gilteritinib (Xospata): Precision Oral Targeted Therapy for FLT3-Mutated AML
7
Macitentan Guide: Dietary Interactions, Contraindications, and Reproductive Safety Protocols
8
Global Update 2026: Selumetinib (KOSELUGO) Expands Indication to Adult NF1-PN and Clinical Management Strategies
9
Lenvatinib Safety Guide: Baseline Assessment & Adverse Reaction Management
10
Donidalorsen (DAWNZERA®) Side Effects and Safety Management Guide
11
Inluriyo (Imlunestrant): Oral SERD for ER+/HER2- Breast Cancer with ESR1 Mutations
12
Idelalisib: Oral PI3Kδ Inhibitor for Relapsed/Refractory Hematologic Malignancies